NL-OMON51863尚未招募不适用
Clinical validation of the NOVEOS immunoassay for allergy diagnostics - Clinical validation of the NOVEOS immunoassay
Reinier de Graaf Groep0 个研究点目标入组 326 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 326
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •Age > 3 years
- •Suspected food allergy to peanut, cow's milk, chicken egg, nuts, sesame seeds,
- •cod and/or wheat.
排除标准
- •Use of anti-IgE injections (Xolair), systemic corticosteroids, or
- •anti-histamines (which should be discontinued three days before performing a
- •skin prik test).
研究者
相似试验
终止
不适用
Validation Study of NOVEOS® System (HYCOR)Allergen-mediated IgE AllergyNCT03969862University Hospital, Montpellier536
已完成
4 期
Study of the immunogenicity and safety of a single dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for each of three successive years in children naïve to, or in previous receipt of the AS03B adjuvanted H1N1 (2009)Topic: Children, Primary CareSubtopic: All Diagnoses, Not AssignedDisease: All Diseases, All DiseasesInfections and InfestationsISRCTN11725083Health Protection Agency (HPA) (UK)254
进行中（未招募）
1 期
Assessing responses to annual nasal flu vaccine in children who have or have not previously been given pandemic flu vaccine.EUCTR2013-003592-35-GBPublic Health England254
招募中
3 期
Clinical Trial of quadrivalent Papilloguard4 vaccine (Human Papillomavirus Types 6, 11, 16, 18) manufactured by Nivad Pharmed Salamat in comparison with GardasilGenital wart prevention.Anogenital (venereal) wartsA63.0IRCT20240120060741N1ivad Pharmed Salamat670
进行中（未招募）
1 期
Immunogenicity and safety of GSK Biologicals’ combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus and Haemophilus influenzae type b (DTPa-IPV/Hib) conjugate vaccine.EUCTR2013-005577-43-Outside-EU/EEAGlaxoSmithKline Biologicals235